Electrical and mechanical support in advanced heart failure: Rationale and feasibility of a combined management strategy

European Heart Journal

Volumn 23, Issue 13, 2002, Pages 1005-1010

  Duru, Firat ^a   Candinas, R ^a   Lachat, M ^a   Rahn, M ^a   Noll, G ^a   Luscher T F ^a   Turina, M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Assist device; Blood pumps; Heart failure; Implantable cardioverter defibrillator; Mechanical support; Transplantation

Indexed keywords

ASSISTED CIRCULATION; CARDIOVERSION; DEFIBRILLATION; EXTRACORPOREAL CIRCULATION; EXTRACORPOREAL OXYGENATION; FEASIBILITY STUDY; HEART ASSIST DEVICE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; IMPLANTATION; PRIORITY JOURNAL; REVIEW;

ADULT; AGED; DEFIBRILLATORS, IMPLANTABLE; FEASIBILITY STUDIES; FEMALE; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0036660249     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.2978     Document Type: Review

References (46)

1. Narang R, Cleland JGF, Erhardt L et al. Mode of death in chronic heart failure. Eur Heart J 1996; 17: 1390-1403.
2. Adams KA, Zannad F. Clinical definition and epidemiology of advanced heart failure. Am J Cardiol 1998; 135: S204-215.
3. Kriett JM, Kaye MP. The Registry of the International Society for Heart and Lung Transplantation: eighth official report 1991. J Heart Lung Transplant 1991; 10: 491-8.
4. McManus RP, O'Hair DP, Beitzinger JM et al. Patients who die awaiting heart transplantation. J Heart Lung Transplant 1993; 12: 159-72.
5. Schmidinger H. The implantable cardioverter defibrillator as a bridge to transplant: a viable clinical strategy? Am J Cardiol 1999; 83: 151D-7D.
6. Stevenson WG, Stevenson LW, Weiss J, Tillisch JH. Inducible ventricular arrhythmias and sudden death during vasodilator therapy of severe heart failure. Am Heart J 1988; 116: 1447-54.
7. Defibrilat Study Group. Actuarial risk of sudden death while awaiting cardiac transplantation in patients with atherosclerotic heart disease. Am J Cardiol 1991; 68: 545-6.
8. Levine JH, Mellits ED, Baumgardner RA et al. Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators. Circulation 1991; 4: 558-66.
9. Bolling SF, Deeb GM, Morady F et al. Automatic internal cardioverter defibrillator: a bridge to heart transplantation. J Heart Lung Transplant 1991; 10: 562-6.
10. Jeevanandam V, Bielefeld MR, Auteri JS et al. The implantable defibrillator: an electronic bridge to transplantation. Circulation 1992; 86: 276-9.
11. Lorga-Filho A, Geelen P, Vanderheyden M et al. Early benefit of implantable cardioverter defibrillator therapy in patients waiting for cardiac transplantation. Pacing Clin Electrophysiol 1998; 21: 1747-50.
12. Novick RJ, Menkis AH, Guiraudon GM et al. Heart transplantation after cardioverter-defibrillator implantation. A case control study. Chest 1993; 103: 1710-14.
13. Saxon LA, Wiener I, DeLurgio DB et al. Implantable defibrillators for high-risk patients with heart failure who are awaiting cardiac transplantation. Am Heart J 1995; 30: 501-6.
14. Trappe HJ, Wenzlaff P. Cardioverter defibrillator therapy as a bridge to heart transplantation. Pacing Clin Electrophysiol 1995; 18: 622-31.
15. Grimm M, Grimm G, Zuckermann A et al. ICD therapy in survivors of sudden cardiac death awaiting heart transplantation. Ann Thorac Surg 1995; 59: 916-20.
16. Sweeney MO, Ruskin JN, Garan H et al. Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation 1995; 92: 3273-81.
17. Kim SG, Fischer JD, Furman S et al. Benefits of implantable defibrillators are overestimated by sudden death rates and better represented by the total arrhythmic death rate. J Am Coll Cardiol 1991; 17: 1587-92.
18. Kim SG. Implantable defibrillator therapy: does it really prolong life? How can we prove it? Am J Cardiol 1993; 71: 1213-18.
19. Block M, Hammel D, Böcker D, Borggrefe M, Breithardt D. Drugs or implantable cardioverter-defibrillators in patients with poor left ventricular function? Am J Cardiol 1996; 78: 62-8.
20. Sheldon R, Connolly S, Krahn A, Roberts R, Gent M, Gardner M on behalf of the CIDS Investigators. Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy. Circulation 2000; 101: 1660-4.
21. Böcker D, Bänsch D, Heinecke A et al. Potential benefit from ICD therapy in patients with and without heart failure. Circulation 1998; 98: 1636-43.
22. Packer M. Treatment of chronic heart failure. Lancet 1992; 340: 92-5.
23. Frazier OH. First use of an unethered, vented electric left ventricular assist device for long-term support. Circulation 1994; 89: 2908-14.
24. Muller J, Wallukat G, Weng YG et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation 1997; 96: 542-9.
25. Jaski BE, Lingle RJ, Reardon LC, Dembitsky WP. Left ventricular assist device as a bridge to patient and myocardial recovery. Prog Cardiovasc Dis 2000; 43: 5-18.
26. Dembitsky WP. Bridging from acute to chronic devices. Ann Thorac Surg 1999; 68: 724-8.
27. DeBakey ME. A miniature implantable axial flow ventricular assist device. Ann Thorac Surg 1999; 68: 637-40.
28. Wieselthaler GM, Schima H, Hiesmayr M et al. First clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation. Circulation 2000; 101: 356.
29. Noon GP, Morley D, Irwin S, Benkowski R. Development and clinical application of the MicroMed DeBakey VAD. Curr Opin Cardiol 2000; 15: 166-71.
30. Wilhelm MJ, Hammel D, Schmid C et al. Clinical experience with nine patients supported by the continuous flow Debakey VAD. J Heart Lung Transplant 2001; 20: 201.
31. Potapov EV, Loebe M, Nasseri BA et al. Pulsatile flow in patients with a novel nonpulsatile implantable ventricular assist device. Circulation 2000; 102 (III): 183-7.
32. Westaby S, Banning AP, Jarvik R et al. First permanent implant of the Jarvik 2000 Heart. Lancet 2000; 356: 900-3.
33. Frazier OH, Myers TJ, Jarvik RK et al. Research and development of an implantable, axial-flow left ventricular assist device: the Jarvik 2000 Heart. Ann Thorac Surg 2001; 71: S125-32.
34. Frazier OH, Gregoric ID, Delgado RM et al. Initial experience with the Jarvik 2000 left ventricular assist system as a bridge to transplantation: report of 4 cases. J Heart Lung Transplant 2001; 20: 201.
35. Griffith BP, Kormos RL, Borovetz HS et al. HeartMate II left ventricular assist system: from concept to first clinical use. Ann Thorac Surg 2001; 71: S116-20.
36. Maher TR, Butler KC, Poirier VL, Gernes DB. Heartmate left ventricular assist devices: a multigeneration of implanted blood pumps. Artif Organs 2001; 25: 422-6.
37. Dowling RD, Etoch SW. Clinically available extracorporeal assist devices. Prog Cardiovasc Dis 2000; 43: 27-36.
38. McCarthy PM, Hoercher K. Clinically available intracorporeal left ventricular assist devices. Prog Cardiovasc Dis 2000; 43: 37-46.
39. Finlayson D. Con: nonpulsatile flow is preferable to pulsatile flow during cardiopulmonary bypass. J Cardiothorac Anesth 1987; 1: 169-70.
40. Shevde K, DeBois W. Pro: pulsatile flow is preferable to nonpulsatile flow during cardiopulmonary bypass. J Cardiothorac Anesth 1987; 1: 165-8.
41. Taenaka Y, Tatsumi E, Nakamura H et al. Physiologic reaction of awake animals to an immediate switch from a pulsatile to nonpulsatile systemic circulation. ASAIO Trans 1990; 36: M541-4.
42. Taylor KM, Bain WH, Davidson KG, Turner MA. Comparative clinical study of pulsatile and non-pulsatile perfusion in 350 consecutive patients. Thorax 1982; 37: 324-30.
43. Undar A, Fraser CD Jr. Influence of pulsatile and nonpulsatile left heart bypass on the hormonal circadian rhythm. ASAIO J 2001; 47: 305-7.
44. Deng MC, Tjan TDT, Asfour B et al. Combining nonpharmacologic therapies for advanced heart failure: The Münster experience with the assist device-defibrillator combination. Am J Cardiol 1999; 83: 158D-60D.
45. Skinner JL, Bourge RC, Shepard RB, Epstein AE, Holman WL. Simultaneous use of an implanted defibrillator and ventricular assist device. Ann Thorac Surg 1997; 64: 1156-8.
46. Ankersmit HJ, Wieselthaler GA, Moser B et al. Automated implantable cardiac defibrillator and biventricular Thoratec assist device as bridge to transplantation in a patient with sarcoidosis. J Thorac Cardiovasc Surg 2001; 121: 1198-9.